Q4 2025 · 13F-HR
Rhenman & Partners Asset Management ABholdings as filed
Filed 2026-02-13 · accession 0001213900-26-015821
$1.07B
Reported value
94
Positions
2025-12-31
Period end
The Brief · Rhenman & Partners Asset Management AB · Q4 2025
AI · grounded in 13F
Rhenman & Partners Asset Management AB closed its position in EXK, reducing exposure by $19.0M. The fund also exited positions in CAH and ABT, totaling $14.8M and $13.2M respectively. To offset these sales, the fund established new positions in AMGN for $11.8M and PNTG for $10.1M. Additionally, the fund increased its share count in VERA by 223.1% and NUVL by 211.1%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $47.4M | 4.43% | 61,400 | Common | SOLE |
| 532457108 | LLY | LILLY ELI & CO | $45.4M | 4.24% | 42,220 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $41.1M | 3.84% | 431,207 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $28.4M | 2.66% | 296,000 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $27.2M | 2.54% | 48,000 | Common | SOLE |
| 216648501 | COO | COOPER COS INC | $26.8M | 2.51% | 327,500 | Common | SOLE |
| 126650100 | CVS | CVS HEALTH CORP | $26.6M | 2.49% | 335,500 | Common | SOLE |
| 00287Y109 | ABBV | ABBVIE INC | $25.3M | 2.36% | 110,575 | Common | SOLE |
| 377322102 | GKOS | GLAUKOS CORP | $23.7M | 2.22% | 210,000 | Common | SOLE |
| 235851102 | DHR | DANAHER CORPORATION | $22.7M | 2.12% | 99,052 | Common | SOLE |
| 03073E105 | COR | CENCORA INC | $21.4M | 2.00% | 63,375 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $21.3M | 1.99% | 420,000 | Common | SOLE |
| 58155Q103 | MCK | MCKESSON CORP | $21.0M | 1.96% | 25,600 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $21.0M | 1.96% | 114,800 | Common | SOLE |
| 01625V104 | ALHC | ALIGNMENT HEALTHCARE INC | $19.9M | 1.86% | 1,009,450 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $19.8M | 1.85% | 113,585 | Common | SOLE |
| 883556102 | TMO | THERMO FISHER SCIENTIFIC INC | $19.5M | 1.82% | 33,640 | Common | SOLE |
| 74276L105 | PRCT | PROCEPT BIOROBOTICS CORP | $19.2M | 1.80% | 611,000 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $18.2M | 1.70% | 45,675 | Common | SOLE |
| 91324P102 | UNH | UNITED HEALTH GROUP INC | $18.1M | 1.69% | 54,900 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $17.8M | 1.66% | 125,491 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $17.3M | 1.62% | 61,000 | Common | SOLE |
| 26622P107 | DOCS | DOXIMITY INC | $16.5M | 1.54% | 372,750 | Common | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCES CORP | $16.5M | 1.54% | 193,500 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $16.4M | 1.54% | 163,350 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $16.3M | 1.52% | 92,350 | Common | SOLE |
| 92532F100 | VRTX | VERTEX PHARMACEUTICALS INC | $15.5M | 1.45% | 34,255 | Common | SOLE |
| 29261A100 | EHC | ENCOMPASS HEALTH CORP | $15.5M | 1.45% | 146,263 | Common | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $15.5M | 1.45% | 126,150 | Common | SOLE |
| 016255101 | ALGN | ALIGN TECHNOLOGY INC | $15.5M | 1.44% | 99,000 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $15.2M | 1.42% | 76,504 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $12.8M | 1.19% | 215,000 | Common | SOLE |
| G50871105 | JAZZ | JAZZ PHARMACEUTICALS PLC | $12.6M | 1.18% | 74,030 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $12.5M | 1.17% | 158,500 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $11.8M | 1.10% | 36,000 | Common | SOLE |
| G5509L101 | LIVN | LIVANOVA PLC | $11.7M | 1.09% | 190,000 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $11.4M | 1.06% | 19,550 | Common | SOLE |
| 125523100 | CI | THE CIGNA GROUP | $10.6M | 0.99% | 38,650 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $10.3M | 0.96% | 147,600 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $10.2M | 0.96% | 487,000 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $10.2M | 0.95% | 537,500 | Common | SOLE |
| 70805E109 | PNTG | PENNANT GROUP INC | $10.1M | 0.94% | 357,346 | Common | SOLE |
| 00650F109 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $9.8M | 0.92% | 605,000 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $9.8M | 0.92% | 31,500 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $9.6M | 0.90% | 144,500 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $9.4M | 0.88% | 374,450 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $9.3M | 0.87% | 40,500 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY IN | $9.1M | 0.85% | 872,000 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $8.7M | 0.81% | 133,500 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA Biosciences Inc | $8.6M | 0.81% | 250,000 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $8.4M | 0.78% | 106,255 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $8.2M | 0.76% | 80,000 | Common | SOLE |
| G7709Q104 | RPRX | ROYALTY PHARMA PLC | $8.0M | 0.75% | 206,500 | Common | SOLE |
| 10950A106 | BTSG | BRIGHTSPRING HEALTH SVCS INC | $7.4M | 0.69% | 198,000 | Common | SOLE |
| 116794108 | BRKR | BRUKER CORP | $6.9M | 0.65% | 147,315 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $6.9M | 0.64% | 216,000 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $6.2M | 0.58% | 81,600 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $6.2M | 0.58% | 139,000 | Common | SOLE |
| 03675P102 | AVR | ANTERIS TECHNOLOGIES GLOBAL | $6.2M | 0.58% | 1,238,625 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $6.2M | 0.58% | 25,000 | Common | SOLE |
| 46266C105 | IQV | IQVIA HLDGS INC | $6.0M | 0.56% | 26,500 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE HLDGS PLC | $5.3M | 0.50% | 153,278 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC | $5.3M | 0.49% | 15,000 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $5.2M | 0.48% | 142,571 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $4.8M | 0.45% | 364,000 | Common | SOLE |
| 159864107 | CRL | CHARLES RIV LABS INTL INC | $4.4M | 0.41% | 22,000 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $4.4M | 0.41% | 1,595,327 | Common | SOLE |
| 92346J108 | VCEL | VERICEL CORP | $4.2M | 0.39% | 117,000 | Common | SOLE |
| 252828108 | DNTH | DIANTHUS THERAPEUTICS INC | $4.1M | 0.38% | 98,627 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $3.9M | 0.36% | 460,000 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $3.7M | 0.35% | 35,000 | Common | SOLE |
| 687793109 | OSCR | OSCAR HEALTH INC | $3.7M | 0.35% | 260,000 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $3.7M | 0.35% | 133,250 | Common | SOLE |
| 750491102 | RDNT | RADNET INC | $3.4M | 0.31% | 47,000 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $3.3M | 0.31% | 35,800 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $3.2M | 0.30% | 265,000 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $3.2M | 0.30% | 15,000 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $3.1M | 0.29% | 225,377 | Common | SOLE |
| 74276R102 | PRVA | PRIVIA HEALTH GROUP INC | $3.0M | 0.28% | 125,000 | Common | SOLE |
| T9224W109 | STVN | STEVANATO GROUP S P A | $3.0M | 0.28% | 147,025 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $2.9M | 0.27% | 83,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $2.8M | 0.26% | 44,375 | Common | SOLE |
| 00846U101 | A | AGILENT TECHNOLOGIES INC | $2.7M | 0.25% | 20,000 | Common | SOLE |
| 98401F105 | XNCR | XENCOR INC | $2.5M | 0.24% | 165,750 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $2.5M | 0.23% | 100,000 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $2.2M | 0.20% | 73,250 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $2.0M | 0.19% | 20,870 | Common | SOLE |
| 955306105 | WST | WEST PHARMACEUTICAL SVSC INC | $1.9M | 0.18% | 7,000 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $1.9M | 0.18% | 46,231 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $1.9M | 0.18% | 79,375 | Common | SOLE |
| 24823R105 | DNLI | DENALI THERAPEUTICS INC | $1.7M | 0.15% | 100,000 | Common | SOLE |
| G8473T100 | STE | STERIS PLC | $1.5M | 0.14% | 6,000 | Common | SOLE |
| 450056106 | IRTC | IRHYTHM TECHNOLOGIES INC | $1.2M | 0.12% | 7,000 | Common | SOLE |
| 02081G201 | ATEC | ALPHATEC HLDGS INC | $420,800 | 0.04% | 20,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.